THENA Capital
Overview
THENA Capital is a London-based venture capital firm that invests in early-stage UK medical technology companies, focusing on digital health, medical devices, and women's health.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Plexāā | Jul 2025 | Grant | Lead |
| Sanome | Mar 2026 | Seed | Lead |
| Salient Bio | Sep 2025 | Seed | Lead |
| Heim | Mar 2026 | VC Round | Lead |
| MyMynd | May 2022 | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Tatum Getty
Founding General Partner
Jason C. Foster
Venture Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is THENA Capital based?
THENA Capital is headquartered in London, United Kingdom.
When was THENA Capital founded?
THENA Capital was founded in 2021.
How many portfolio companies does THENA Capital have?
THENA Capital has 6 portfolio companies in Caplight's dataset.
What are some companies in THENA Capital's portfolio?
Portfolio companies visible on Caplight include Plexāā, Sanome, Salient Bio, Heim, MyMynd.
What was THENA Capital's most recent investment shown here?
THENA Capital's most recent investment in this portfolio sample was in Heim in 2026.
What sectors does THENA Capital focus on?
THENA Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does THENA Capital focus on?
THENA Capital typically invests at the Early stage.
What is THENA Capital's AUM?
THENA Capital's assets under management are estimated between $43.2M and $63.5M.